Arcinova is a Contract Research and Development Organisation (CRDO), providing a comprehensive range of integrated specialist services, spearheading the use of new technology processes to support the development of pioneering drugs for the treatment of life-threatening illnesses.
This is an exciting time for Arcinova. We have a fantastic team, a world-class facility and strong market opportunity. We selected BGF because of its long-term approach to investing, and its ability to provide additional funding as we embark on a period of capital expenditure and international expansion.Professor Ian Shott, executive chair
Business funding insights
BGF explains: Is private equity the best way to fund an M&A growth strategy?
What to consider when seeking private equity funding for acquisitive growth, from investment timelines to deal types and more
BGF explains: what do private equity investors look for in a business?
We explain what private equity investors look for in the businesses they invest in, from your growth plan to your management team.